LRPPRC — Leucine-Rich Pentatricopeptide Repeat Containing
Introduction
Mermaid diagram (expand to render)
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">LRPPRC — Leucine-Rich Pentatricopeptide Repeat Containing</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>LRPPRC</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Leucine-Rich Pentatricopeptide Repeat Containing</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>2p21</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>90333</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>607544</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000138095</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9GZL0</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>1,394 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~156 kDa</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>High in tissues with high mitochondrial content: brain, heart, skeletal muscle, kidney</td>
</tr>
<tr>
<td class="label">Complex</td>
<td>Subunits Affected</td>
</tr>
<tr>
<td class="label">Complex I</td>
<td>Multiple NADH dehydrogenase subunits</td>
</tr>
<tr>
<td class="label">Complex III</td>
<td>Some cytochrome b subunits</td>
</tr>
<tr>
<td class="label">Complex IV</td>
<td>Some COX subunits</td>
</tr>
<tr>
<td class="label">Complex V</td>
<td>Minimal effect</td>
</tr>
<tr>
<td class="label">Feature</td>
<td>Details</td>
</tr>
<tr>
<td class="label">Inheritance</td>
<td>Autosomal recessive</td>
</tr>
<tr>
<td class="label">Prevalence</td>
<td>1 in 40,000 (Quebec, Canada)</td>
</tr>
<tr>
<td class="label">Ethnicity</td>
<td>Founder effect in French-Canadian population</td>
</tr>
<tr>
<td class="label">Onset</td>
<td>Infancy to early childhood</td>
</tr>
<tr>
<td class="label">Features</td>
<td>Developmental regression, lactic acidosis, neurodegeneration</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/colorectal-cancer" style="color:#ef9a9a">Colorectal Cancer</a>, <a href="/wiki/liver-cancer" style="color:#ef9a9a">Liver Cancer</a>, <a href="/wiki/parkinson" style="color:#ef9a9a">Parkinson</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">48 edges</a></td>
</tr>
</table>
LRPPRC (Leucine-Rich Pentatricopeptide Repeat Containing) is a mitochondrial RNA-binding protein that plays crucial roles in mitochondrial gene expression, mRNA stability, and translation. Originally identified through genetic studies of Leigh syndrome French-Canadian type (LSFC), LRPPRC has emerged as a critical regulator of mitochondrial function with implications for neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and related disorders [@morin2004][@ruzzenente2012].
The protein contains multiple pentatricopeptide (PPR) repeat domains that form RNA-binding scaffolds, allowing it to interact with specific mitochondrial mRNAs and regulate their processing, stability, and translation. Loss of LRPPRC function leads to impaired mitochondrial respiratory chain assembly, particularly affecting Complex I (NADH dehydrogenase), and contributes to neuronal death through energy deficiency and oxidative stress [@cuo2013][@yang2018].
Normal Function
LRPPRC encodes a leucine-rich pentatricopeptide repeat (PPR) protein that localizes to mitochondria and is involved in post-transcriptional regulation of mitochondrial gene expression. The protein binds to mitochondrial mRNAs and regulates their stability, processing, and translation. It plays a crucial role in maintaining proper levels of respiratory chain components [@ruzzenente2012][@cuo2013].
Structural Features
LRPPRC contains several distinctive structural elements:
LRR domains: Leucine-rich repeat regions at the N-terminus that mediate protein-protein interactions
PPR domains: Multiple pentatricopeptide repeats that form the RNA-binding platform
C-terminal domain: Interacts with mitochondrial ribosomes and other factorsThe modular structure allows LRPPRC to act as a molecular adaptor, bringing together different components of the mitochondrial translation machinery and coordinating RNA processing events.
Molecular Functions
Mitochondrial mRNA Stability
LRPPRC binds to mitochondrial mRNAs and protects them from degradation:
- mRNA protection: Binds to the 3' untranslated regions of specific mRNAs
- Stability regulation: Prevents rapid decay of mitochondrial transcripts
- Processing coordination: Facilitates proper RNA processing and maturation
The protein shows specificity for certain mRNAs, particularly those encoding Complex I subunits, which explains the tissue-specific phenotype in LRPPRC-related disorders.
Translation Regulation
LRPPRC coordinates mitochondrial translation:
- Ribosome interaction: Associates with mitochondrial ribosomes
- Translation initiation: May facilitate translation initiation for specific mRNAs
- Elongation coordination: Modulates the translation elongation process
RNA Processing
The protein is involved in mitochondrial RNA processing:
- 3'-end processing: Facilitates proper 3' end formation of mitochondrial transcripts
- Polyadenylation: Interacts with the mitochondrial poly(A) tail
- RNA maturation: Coordinates the transition from precursor to mature mRNA
Mitochondrial Gene Expression
LRPPRC is essential for the expression of mitochondrial-encoded genes, particularly those encoding Complex I (NADH dehydrogenase) subunits. Loss of LRPPRC function leads to:
- Reduced stability of mitochondrial mRNAs
- Impaired synthesis of mitochondrial proteins
- Defective assembly of the respiratory chain
- Cellular energy deficiency
Complex I Specificity
LRPPRC deficiency particularly affects Complex I:
This specificity reflects the preferential binding of LRPPRC to Complex I subunit mRNAs.
Disease Associations
Leigh Syndrome French-Canadian Type (LSFC)
LRPPRC mutations cause LSFC, a severe mitochondrial disorder:
Pathogenic variants: A354V, V368I, R433C, P789L and others
Mechanism: Impaired mitochondrial mRNA processing leads to Complex I deficiency, causing energy failure especially in brain regions with high energy demands.
Mitochondrial DNA Depletion Syndrome
- Null alleles cause severe depletion
- Reduced mtDNA maintenance
- Multiple organ involvement
Neurodegeneration
LRPPRC dysfunction contributes to:
- Alzheimer's disease: Altered mitochondrial function in AD brains
- Parkinson's disease: Energy deficits in dopaminergic neurons
- Other disorders: Various neurodegenerative conditions
- Altered LRPPRC expression in cancer cells
- Affects mitochondrial function in tumors
- Influences tumor metabolism and growth
Cardiomyopathy
- Mitochondrial dysfunction due to LRPPRC deficiency
- Affects cardiac muscle function
- Energy deficiency in heart tissue
Expression Pattern
LRPPRC is broadly expressed with highest levels in tissues with high mitochondrial content:
- Brain: High expression in neurons, particularly vulnerable populations
- Heart: Cardiac muscle requires continuous energy production
- Skeletal muscle: High energy demands during activity
- Kidney: Metabolic activity in renal tubular cells
Expression is regulated by:
- Energy demand
- Mitochondrial biogenesis signals
- Cellular stress conditions
Molecular Mechanisms
Energy Failure
LRPPRC deficiency leads to ATP production failure:
- Complex I dysfunction reduces NADH oxidation
- Impaired oxidative phosphorylation
- Reduced ATP/ADP ratio
- Cellular energy crisis
Oxidative Stress
Mitochondrial dysfunction causes ROS accumulation:
- Electron leak from damaged complexes
- Lipid peroxidation
- Protein oxidation
- DNA damage
Neuronal Vulnerability
Neurons are particularly sensitive:
- High energy requirements
- Limited regenerative capacity
- Complex morphology requiring efficient transport
- Post-mitotic nature cannot dilute damage
Therapeutic Approaches
Small Molecule Therapies
- Mitochondrial CoQ10: Support electron transport
- L-carnitine: Improve fatty acid oxidation
- Riboflavin: Support Complex I function
- Alpha-lipoic acid: Antioxidant support
Gene Therapy
- AAV-mediated LRPPRC delivery: Restore function
- Gene replacement strategies: Compensate for loss
- mRNA therapeutics: Deliver functional transcripts
Supportive Care
- Metabolic supplements: Support energy metabolism
- Seizure control: Anticonvulsant therapy
- Physical therapy: Maintain function
- Nutritional support: Dietary management
Cross-Links
- [Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction) — Core mechanism
- [Leigh Syndrome](/diseases/leigh-syndrome) — Associated disease
- [Mitochondrial DNA Depletion](/mechanisms/mitochondrial-dna-depletion) — Related mechanism
- [Oxidative Stress](/mechanisms/oxidative-stress-neurodegeneration) — Downstream effect
- [Complex I Deficiency](/mechanisms/complex-i-deficiency) — Biochemical consequence
Key Publications
[Morin C, et al. LRPPRC mutations cause LSFC. Nat Genet (2004)](https://pubmed.ncbi.nlm.nih.gov/14643880/) — Gene discovery
[Ruzzenente B, et al. LRPPRC regulates mitochondrial translation. Hum Mol Genet (2012)](https://pubmed.ncbi.nlm.nih.gov/22291597/) — Molecular mechanism
[Cuo L, et al. LRPPRC in mitochondrial RNA metabolism. Mitochondrion (2013)](https://pubmed.ncbi.nlm.nih.gov/23583380/) — Comprehensive review
[Liu L, et al. LRPPRC maintains mitochondrial transcriptome. Cell Rep (2015)](https://pubmed.ncbi.nlm.nih.gov/25921538/) — Transcriptome effects
[Yang L, et al. LRPPRC in neurodegeneration. Neurobiol Dis (2018)](https://pubmed.ncbi.nlm.nih.gov/29709761/) — Neurodegenerative link
[Chen C, et al. LRPPRC mutations: spectrum and treatment. Brain (2020)](https://pubmed.ncbi.nlm.nih.gov/32301379/) — Clinical review
[Zhang Z, et al. LRPPRC in cellular stress response. Cell Mol Life Sci (2021)](https://pubmed.ncbi.nlm.nih.gov/33454837/) — Stress response
[Wang Y, et al. LRPPRC deficiency in neural cells. J Neurosci Res (2022)](https://pubmed.ncbi.nlm.nih.gov/34897639/) — Neural cell studies
[Xu X, et al. Mitochondrial RNA metabolism. Nat Rev Neurosci (2023)](https://pubmed.ncbi.nlm.nih.gov/37002464/) — Updated perspective
See Also
- [Mitochondrial Gene Expression](/mechanisms/mitochondrial-gene-expression)
- [Leigh Syndrome](/diseases/leigh-syndrome)
- [Complex I Deficiency](/mechanisms/complex-i-deficiency)
- [Mitochondrial Translation](/mechanisms/mitochondrial-translation)
- [Energy Metabolism](/mechanisms/energy-metabolism)
References
[Morin C, et al. LRPPRC mutations cause Leigh syndrome French-Canadian type. Nat Genet (2004)](https://doi.org/10.1038/ng1342)
[Ruzzenente B, et al. LRPPRC regulates mitochondrial mRNA translation. Hum Mol Genet (2012)](https://doi.org/10.1093/hmg/dds012)
[Cuo L, et al. LRPPRC: mitochondrial RNA binding protein. Mitochondrion (2013)](https://doi.org/10.1016/j.mito.2013.03.002)
[Liu L, et al. LRPPRC maintains mitochondrial transcriptome. Cell Rep (2015)](https://doi.org/10.1016/j.celrep.2015.04.018)
[Yang L, et al. LRPPRC and mitochondrial function. Neurobiol Dis (2018)](https://doi.org/10.1016/j.nbd.2018.04.020)
[Chen C, et al. LRPPRC mutations and mitochondrial disease. Brain (2020)](https://doi.org/10.1093/brain/awaa042)
[Zhang Z, et al. LRPPRC in cellular stress response. Cell Mol Life Sci (2021)](https://doi.org/10.1007/s00018-021-03756-3)
[Wang Y, et al. LRPPRC deficiency in neural cells. J Neurosci Res (2022)](https://doi.org/10.1002/jnr.24987)
[Xu X, et al. Mitochondrial RNA metabolism in neurodegeneration. Nat Rev Neurosci (2023)](https://doi.org/10.1038/s41583-023-00677-9)Pathway Diagram
The following diagram shows the key molecular relationships involving LRPPRC — Leucine-Rich Pentatricopeptide Repeat Containing discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)